Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.58 USD | +3.20% | -1.16% | -58.37% |
Feb. 27 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
Feb. 27 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 17.48M |
---|---|---|---|---|---|
Net income 2024 * | -32M | Net income 2025 * | -54M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.7
x | P/E ratio 2025 * |
-0.55
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.74% |
Latest transcript on Minerva Neurosciences, Inc.
1 day | -2.72% | ||
1 week | -7.41% | ||
Current month | -6.37% | ||
1 month | -10.71% | ||
3 months | -61.54% | ||
6 months | -65.75% | ||
Current year | -59.35% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 14-02-28 | |
Geoff Race
FOU | Founder | 63 | 10-06-30 |
Fred Ahlholm
DFI | Director of Finance/CFO | 58 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeryl Hilleman
BRD | Director/Board Member | 66 | 18-07-16 |
Jan van Heek
BRD | Director/Board Member | 75 | 14-06-30 |
Director/Board Member | 68 | 17-12-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.56 | +2.40% | 11 240 |
24-03-27 | 2.5 | -2.72% | 34,730 |
24-03-26 | 2.57 | -3.38% | 37,013 |
24-03-25 | 2.66 | -0.37% | 12,329 |
24-03-22 | 2.67 | +3.09% | 29,335 |
Delayed Quote Nasdaq, March 27, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.35% | 17.48M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.19% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |